Dr. Parthopratim Dutta Majumder

Senior Consultant, Department of Uvea , Sankara Nethralaya, Chennai

24 articles

Parthopratim Dutta Majumder completed his graduation and post-graduation from Silchar Medical College, Assam University. He pursued his fellowship in Medical Retina and Uvea at Sankara Nethralaya and currently holds the position of Professor and senior consultant in the same department. With a remarkable career, he has garnered numerous accolades, including the Dr. TLK Row Endowment Award for the best associate consultant (2010-11), the Dr. Nataraj Pillai Award, The Best of IJO, and the Dr. K. R. Dutta Award. As a distinguished speaker, Parthopratim has delivered more than 290+ talks at various national and international meetings, sharing his expertise and insights. He has published more than 200+ research articles across diverse peer-reviewed and non-peer-reviewed journals. In recognition of his expertise, Prof. Dutta Majumder has held esteemed editorial positions and associated various journals and serving as reviewer for many of them. Prof. Dutta Majumder's expertise extends to the realm of academic writing, having authored over 70+ chapters in various ophthalmology books. He has also authored four books. Parthopratim has been ranked among the world's top 2% of scientists in 2024 and 2025, according to the Scientist's List by Stanford University. He currently serves as the Secretary of the Uveitis Society of India (USI). He has served the society earlier as treasurer. He is a member of the International Uveitis Study Group (IUSG), Intraocular Inflammation Society (IOIS). He is actively involved in teaching and various curricular activities with various organizations and societies. Notably, he is also the Founder cum Chief Editor of the popular ophthalmology portal www.eophtha.com

  1. Students Gallery 8 May 2026 9 min read

    Five Tips to Start Writing Your Thesis

    1. Conducting a Literature Review A rigorous literature review is the backbone of every research project. It defines what is known, identifies gaps, and justifies your study — yet it is frequently done poorly. Getting Started Define first, search second: Define your topic clearly and precisely before searching. A broad question leads to an unmanageable volume of literature; a narrow question may miss important context. Frame your four questions: Ask four key questions: What do I already know? What gaps exist? What is controversial? What still needs studying? These guide your search strategy and eventual write-up. Search multiple databases: Use multiple databases (PubMed, CINAHL, Cochrane, Web of Science, Google Scholar) and do not rely on a single source. How to search PubMed: A Ready Reckoner for ... Document your search strategy: Record your search strategy (databases used, keywords, date range, filters applied) so it can be reported and reproduced. Pearl: A good literature review ha

  2. Articles 6 Sep 2025 3 min read

    Six Useful Apps and Glasses for Colourblind Patients: A Guide for Ophthalmologists

    Colourblindness makes many everyday tasks difficult—such as recognizing traffic signals, selecting clothes, or interpreting colour-coded information. For those affected, even simple activities can become challenging. At present, there is no permanent treatment available for colourblindness. However, ophthalmologists can play an important role in improving patients’ daily lives by recommending effective visual aids. With recent advances, several options are now within easy reach. Mobile applications can instantly identify and label colours, while specially designed glasses can enhance colour perception, particularly in red-green colourblindness. This short write-up highlights six practical aids—both apps and glasses—with links for direct access. By guiding patients to these resources, ophthalmologists can help them adapt better and manage their condition with greater confidence. 1. EnChroma Glasses EnChroma is a world leader in colourblind glasses designed to enhance red-green colour di

  3. Articles 29 Aug 2025 9 min read

    New Frontiers in Uveitis Management: Five Drugs to Watch

    The management of uveitis is rapidly evolving with the introduction of novel therapeutic molecules targeting key inflammatory pathways. This article highlights five promising drugs currently under clinical evaluation, offering hope for more effective and safer treatment options. While early results are encouraging, most of these agents are yet to complete phase 3 trials, and their long-term safety and efficacy remain to be established. Until then, clinicians must remain cautiously optimistic and await further evidence before these therapies can reshape uveitis care. 1. Brepocitinib Brepocitinib is an oral small-molecule inhibitor targeting Janus kinase 1 (JAK 1) and tyrosine kinase 2 (TYK2). Unlike many other JAK inhibitors that may block several JAK family kinases broadly (JAK1, JAK2, JAK3), brepocitinib selectively inhibits TYK2 and JAK1 while sparing JAK2 and JAK3 to a significant degree. This selectivity translates into targeted suppression of key pro-inflammatory cytokines—such as

  4. Students Gallery 19 Jul 2021 4 min read

    Triads, Dots, Spots, Lines

    Spots Bitot's spot=White, foamy area of keratinizing squamous metaplasia of bulbar conjunctiva, seen in vitamin A deficiency. Brushfield spot=Whitish grey spot in peripheral iris, seen in Down's syndrome. Elschnig spot=Yellow patches overlying area of choroidal infarction in hypertension. Fischer-Khunt spot=Senile scleral plaque, area of hyalinised sclera anterior horizontal rectus muscle insertion. Seen in old age. Fuch's spot=Pigmented (RPE hyperplasia) macular lesions in pathological myopia. Roth spots=haemorrhageswith white centers, seen in SABE, severe anemia, collagen vascular disorders. Dots Gunn's dot=light reflection from the internal limiting membrane around disc and macula Horner-Trantras Dot=Collections of eosinophils at the limbus in vernal conjunctivitis. Kayes' dot=subepithelial infiltrates seen in corneal graft rejection Mittendorf's dot=whitish spot at the posterior lens surface, the remnant of the hyaloid artery. Lines Arlt's Line = conjunctival scar in sulcus subtars

  5. Interesting Reads 2 Apr 2021 5 min read

    Trivia

    Do you Know !! The eye muscles are the most active muscles in the whole body. The external muscles that move ht eyes are the strongest muscles in the human body for the job that they have to do. They are 100 times powerful than they need to be. Eyes are composed of more than two million working parts. The eye can process 36,000 bits of information every hour. A normal lifespan will bring you almost 24 million of images of the world around you. Eyes can instantaneously set in motion hundreds of muscles & organs in our body. A blink of an eye lasts about one-tenth of a second. The average persons blink their eyes about 11,500 times per day and about 4.2 million times per year. Dacryphilia is the arousal from seeing tears in the eyes of a partner. Chewing gum while peeling onions will keep you away from crying. Men can read smaller print than women, women can hear well. You can’t sneeze with your eyes open (you can try it!!) Everyone is colour blind at birth. The eye is the only part of t

  6. Anatomy of eye 2 Apr 2021 12 min read

    Anatomy of Conjunctiva

    Conjunctiva is a fine, translucent mucous membrane that joins and covers the anterior surface of eyeball and posterior side of the eyelids. It covers the posterior surface of the lids and reflects to cover the anterior part of the sclera, then becomes continuous with the corneal epithelium. At the lid margin conjunctiva is continuous with the skin. The name “conjunctiva” has originated from the term “conjoin” which means “to join” Parts of the conjunctiva: Broadly conjunctiva is divided into palpebral conjunctiva, fornices, and bulbar conjunctiva. Palpebral conjunctiva: It is the part of the conjunctiva that lines the undersurface or posterior surface of the eyelid. Latin word palpebrae mean “an eyelid” The palpebral conjunctiva is again subdivided into marginal conjunctiva, tarsal conjunctiva, and orbital conjunctiva. The marginal conjunctiva is a transitional zone between the skin of the eyelid and the conjunctiva proper. It starts from the intermarginal strips of the eyelid as a con

  7. Students Gallery 2 Apr 2021 6 min read

    Documentation & Drawing in Ophthalmology

    Anterior segment finding Documentations From the days of Hippocrates documentation has been a cornerstone of clinical science. But somewhere down the line this has become a lost art rarely ever practiced by many of us. We tend to ignore or to say correctly run away from it under many pretexts like its time consuming, it’s of no use, etc. And surprisingly this resistance to document is prevalent not only among juniors but spans across the whole spectrum of practitioners. So at times we really ponder is documentation really necessary? The answer is an emphatic yes – the reasons being It’s a standard clinical practice worldwide Follow up is possible only if you can compare it with your previous records. Will help you medico legally Last but not the least unless you are documenting it you have not probably seen it correctly(you think you have seen it all but the moment you come to draw it you find that you don’t remember where the break was it at 1 o’clock or 3 o’clock position and so on).

  8. Interesting Reads 2 Apr 2021 14 min read

    How to make an effective power point presentation

    There is more to a PowerPoint presentation than to make slides and presenting them. The entire process can be divided into a series of steps each of which is extremely important in order to make an effective presentation which could leave a lasting impression on the audience. The steps are summarized as- Getting started- The groundwork Making the PowerPoint Making it better –Getting rid of the rough edges Practise ( makes you perfect) Prelude to the presentation- Acclimatising Presentation – Last but not least Getting started: Knowledge, it is said is power. Having a better understanding of the various aspects of a presentation helps us make it better. Knowing the topic- This step forms the foundation of any presentation. No presentation is complete without proper knowledge of the topic. While preparing, the presenter must make an effort to read from many sources in order to have a better understanding of the topic. Latest articles regarding the topic can be looked upon ww.pubmed.gov w

  9. Interesting Reads 2 Apr 2021 21 min read

    Musings from the Wise in the Covid Era

    We all are in the midst of an unprecedented global crisis due to the COVID-19 pandemic. This global pandemic has changed the ophthalmology practice pattern and there is an atmosphere of growing uncertainty among the ophthalmologists. We three spoke to some of the finest and sharpest minds in Indian ophthalmology and teachers of the teachers. Dr. Amod Gupta is a world-renowned ophthalmologist and teacher of teachers. Dr. Gupta retired from the Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. Dr. Amod Gupta has been a teacher and mentor to many for over four decades. Dr. Gullapalli Nageswara Rao founded the L V Prasad Eye institute in 1987. Dr. G N Rao has shaped many minds in his illustrious career in the field of ophthalmology. He has notable contributions to the advancement of ophthalmology in the nation. He currently holds the honorable position as the Chair of the Academia Ophthalmological Internationalis. Dr. Lingam Gopal is a pion

  10. Articles 1 Apr 2021 20 min read

    Uveitic Macular Edema

    Introduction: Macular edema is defined as swelling of the layers of neurosensory retina within the macula. Cystoid macular edema (CME) is a subtype of macular edema characterized by extracellular accumulation of fluid within the outer plexiform layer of the retina in the form of intraretinal cyst. It is known as one of the complications, that develops consequent to a final common pathway in diverse diseases affecting the blood-retinal barrier. CME is a major cause of visual loss in uveitis. The overall reported prevalence of visual impairment associated with uveitic CME is 33–42 % and is influenced by the age, location, severity, and duration of retinal edema. [1,2] In young age, the retinal tissue shows resistance to development of CME, but advanced age is independently associated with early development of CME, regardless of the duration of uveitis. In contrast, the most frequent causes of visual loss in pediatric uveitis are retinal scars and glaucoma. [3] Panuveitis and intermediate